Trial
NCT00657748
Lithium and Acetate for Canavan Disease
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Assistance Publique - Hôpitaux de Paris
Collaborators
European Leukodystrophy Association
Condition
Canavan Disease
Intervention
Lithium Gluconate (drug) Glyceryl Triacetate GTA (drug)
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-04-21